Author

Y. C. Lee

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

A. A. Silva· 1 shared A. Durandin· 1 shared A. Kolbanovskiy· 1 shared B. N. Brown· 1 shared B. Tomita· 1 shared C.-H. Ho· 1 shared D. A. Fantini· 1 shared D. A. Rao· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. A. Silva

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Ascending and Descending Aortic ECM Hydrogels for Modeling Aortic Wall Biology

Y. C. Lee, T. D. Richards, D. A. Fantini, D. J. Kaczorowski, B. N. Brown, J. A. Phillippi

This study compares the composition and structure of ascending and descending aortic ECM hydrogels to understand their effects on vasa vasorum-associated pericyte behavior.

bioRxiv · Dec 3, 2022 · PreprintBioengineering

The DNA Damage-Sensing NER Repair Factor XPC-RAD23B Does Not Recognize Bulky DNA Lesions with a Missing Nucleotide Opposite the Lesion.

K. M. Feher, A. Kolbanovskiy, A. Durandin, Y. Shim, J. H. Min, Y. C. Lee, V. Shafirovich, H. Mu, S. Broyde, N. E. Geacintov

This study shows that XPC-RAD23B does not bind to DNA lesions with a missing nucleotide opposite the lesion, due to structural stabilization preventing XPC binding.

bioRxiv · Sep 14, 2020Biochemistry

Utilizing a PTPN22 gene signature to predict response to targeted therapies in rheumatoid arthritis

H.-H. Chang, C.-H. Ho, B. Tomita, A. A. Silva, J. A. Sparks, E. W. Karlson, D. A. Rao, Y. C. Lee, I.-C. Ho

The paper identifies a PTPN22 gene signature in RA patients that can be reversed by targeted therapies and correlates with clinical response.

bioRxiv · Mar 24, 2019Immunology